What's happening
This bill guarantees ovarian cancer survivors in New York the right to unrestricted access to genetic and genomic testing.
Why it matters
Improves personalized care. By ensuring ovarian cancer survivors have unrestricted access to advanced genetic and genomic tests (like BRCA1/2 and Lynch syndrome), the bill enables doctors to tailor surveillance and treatment plans more precisely to individual risk profiles.
Removes insurance and procedural barriers. Prohibiting frequency caps and other limitations means that survivors can get tested as often as medically necessary, potentially catching new mutations or recurrences earlier and improving health outcomes.
Supports evolving medical science. By including language that allows testing for "additional mutations if medically necessary," the bill ensures that as research identifies new relevant genetic markers, survivors can benefit from the latest scientific advances without waiting for further legislative updates.
Addresses health disparities. Mandating equal access regardless of insurance status or provider policy helps reduce inequities in care, particularly for lower-income or marginalized patients who might otherwise face denials or delays in obtaining these critical tests.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Ovarian Cancer Survivor Screenings
Plain English, a few words. Used as the page title.
Sponsors
History
- Committed to rules
- Advanced to third reading
- 2nd report cal.
- 1st report cal.1231
- Reported and committed to finance
- Referred to women's issues
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Guarantee Ovarian Cancer Screenings
In Assembly Committee · Health · Sponsor Michaelle C. Solages
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
8879
IN SENATE
April 26, 2022
Introduced by Sen. PERSAUD -- read twice and ordered printed, and when printed to be committed to the Committee on Women's Issues
AN ACT to amend the public health law, in relation to ensuring ovarian cancer survivors have the right to access screenings for health conditions
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 2404-e to read as follows:
§ 2404-e. Ovarian cancer; right to screenings. No person with a personal history of ovarian cancer shall be denied genetic testing or genomic tumor profiling for inherited germline mutations and acquired somatic mutations, respectively. In general, such testing shall not be subject to frequency caps or other limitations and shall include, but not be limited to:
(a) genetic mutations in BRCA1 and BRCA2 genes;
(b) genetic mutations associated with Lynch syndrome;
(c) rearrangement analysis of all coding exons associated with ovarian cancer; and
(d) additional mutations if medically necessary and appropriate, as determined by the health care professional treating the individual.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD14504-02-2
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to ensuring ovarian cancer survivors have the right to access screenings for health condi- tions
Purpose or general idea of bill
The purpose of the bill is to expand preventative health care to patients with a personal or family history of ovarian cancer.
Summary of provisions
Section 1 of the bill adds a new § 2404-e to the public health law to ensure patients with a history of ovarian cancer, the right to have screenings in order to improve their health care in regards to ovarian cancer.
Section 2 of the bill is the effective date.
Justification
Cancer survivors are incredibly strong and resilient people that over- came a deadly disease. Yet, just because they overcame, a disease does not mean that they cannot get cancer once again. One's genetics can increase the likelihood of getting cancer, as well as cancer treatment like chemotherapy, as the immune system is weakened. Because of this it is essential that cancer survivors be given the right to get screening considering that, they can be more vulnerable to getting the disease again.
Cancer survivors have already gone through the pain and tribulations of overcoming the deadly disease, so they should have the right to get preventative care in order to see if they have a higher likelihood of getting cancer once again.
Legislative history
None
Fiscal implications
None noted.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.